BTK inhibitors such as tolebrutinib or evobrutinib work about as well as Aubagio at preventing relapses in MS, a review of studies found.
The U.S. Department of Commerce (DOC) recently released the results of its 19th administrative review of antidumping duty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results